Clinical Trials Directory

Trials / Completed

CompletedNCT04329546

Understanding COVID-19

How Immune Responses Shape Virological and Clinical Characteristics of COVID-19: a Prospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

This single-center prospective observational study will examine immune responses to to SARS-CoV-2 and how they correlate with its virological characteristics and clinical manifestations in infected patients. Household contacts will also be included so that early immune responses and viral kinetics can be captured. Patients and contacts will be followed for 8 and 2 weeks, respectively. The study will include a maximum of 250 participants.

Detailed description

The primary aim of this single-center prospective observational study is to establish how immune responses to SARS-CoV-2 or to cross-reactive viruses correlate with the virological and clinical characteristics of SARS- CoV-2-infected patients and their exposed household contacts. Through iterative sampling, the viral kinetics of at least 50 infected patients will be evaluated in relation to symptom severity and innate and adaptive immune responses, while their household contacts will be observed for viral detection and immune responses. Patients and contacts will be followed for 8 and 2 weeks, respectively. The study will include a maximum of 250 participants.

Conditions

Interventions

TypeNameDescription
OTHERNA (no intervention)NA (no intervention)

Timeline

Start date
2020-03-27
Primary completion
2021-10-31
Completion
2021-12-31
First posted
2020-04-01
Last updated
2022-05-24

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04329546. Inclusion in this directory is not an endorsement.